Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer

Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer

Background: Data from previous work suggests that there is no correlation between systemic (plasma) paclitaxel exposure and efficacy in patients treated for esophageal cancer. In this trial, we investigated ATP-binding cassette efflux transporter expression and intratumoral pharmacokinetics of pacli...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ruben A. G. van Eerden, Leni van Doorn, Femke M. de Man, Niels Heersche, Michail Doukas, Thierry P. P. van den Bosch, Esther Oomen-de Hoop, Peter de Bruijn, Sander Bins, Eman Ibrahim, Suzan Nikkessen, Lena E. Friberg, Stijn L. W. Koolen, Manon C. W. Spaander, Ron H. J. Mathijssen
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
tissue pharmacokinetics
intratumoral
paclitaxel
pharmacokinetics
esophageal cancer
ABCB1
Therapeutics. Pharmacology
RM1-950
Accès en ligne:https://doaj.org/article/2da8bb17075a4bb7a21f579be94bb87f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/2da8bb17075a4bb7a21f579be94bb87f

Documents similaires